Hematopoietic and lymphoid system neoplasm
Therapeutic area
Hematology
Rare disease
No
- Definition
- Neoplasms of the hematopoietic system, including hematopoietic cell neoplasms (e.g. leukemias, lymphomas) and non-hematopoietic cell neoplasms that can affect the hematopoietic system (e.g. lymph node and splenic sarcomas). --2003
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Hematopoietic and lymphoid system neoplasm
- Therapeutic area
- Hematology
- hematopoietic and lymphoid system neoplasm
- haematopoietic neoplasm
- haematopoietic neoplasm (morphologic abnormality)
- hematologic neoplasm
- hematopoietic neoplasm
- hematopoietic neoplasm (morphologic abnormality)
- blood neoplasm (disease)
- blood tumor
- blood tumour
- haematological tumours
- haematopoietic and lymphoid system tumour
- haematopoietic system neoplasm
- haematopoietic system tumour
- haematopoietic tumours
- hematopoietic and lymphoid system neoplasm
- hematopoietic and lymphoid system tumor
- hematopoietic system neoplasm
- hematopoietic system tumor
- neoplasm of blood
- neoplasm of haematopoietic system
- neoplasm of hematopoietic system
- tumor of blood
- tumor of hematopoietic system
- tumour of blood
- tumour of haematopoietic system
And 7 more, listed on the interactive page.
- Severity
- Severe
- Hematology
- Oncology
- MONDO ID
- MONDO:0002334
- Parent condition
- MONDO:0005070
Related records
Broader conditions (8)
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Hematologic disorder
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
Narrower conditions (571)
- A53 diffuse large B-cell lymphoma
- Acquired polycythemia vera
- Acute basophilic leukemia
- Acute biphenotypic leukemia
- Acute erythroid leukemia
- Acute leukemia
- Acute leukemia of ambiguous lineage
- Acute lymphoblastic leukemia
- Acute mast cell leukemia
- Acute megakaryoblastic leukemia
- Acute megakaryoblastic leukemia in adult
- Acute megakaryoblastic leukemia in down syndrome
- Acute megakaryoblastic leukemia without down syndrome
- Acute monocytic leukemia
- Acute myeloblastic leukemia with maturation
- Acute myeloblastic leukemia without maturation
- Acute myeloid leukemia
- Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent
- Acute myeloid leukemia and myelodysplastic syndromes related to radiation
- Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor
Trials (1,474)
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- 18F-Pentixafor PET in Hematologic Malignancies
- 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression
- A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
- A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
- A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
- A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
- A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies
- A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
- A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
- A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
- A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006)
- A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
- A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
- A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care
- A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- A Dose-escalation Study in Subjects With Advanced Malignancies
- A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors
Drugs in development (30)
- Bendamustine Phase 2
- Branebrutinib Phase 1
- Cyclophosphamide Phase 3
- Emavusertib Phase 1
- Emavusertib hydrochloride Phase 1
- Emavusertib maleate Phase 1
- Emavusertib mesylate Phase 1
- Emavusertib phosphate Phase 1
- Emavusertib tosylate Phase 1
- Filgrastim Phase 2
- Fludarabine Phase 2
- Gusacitinib Phase 1
- Gusacitinib hydrochloride Phase 1
- Linrodostat Phase 1
- Linrodostat mesylate Phase 1
- Melphalan Phase 2
- Mivavotinib Phase 1
- Mivavotinib citrate Phase 1
- Mocravimod Phase 1
- Mocravimod hydrochloride Phase 1